Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AQB | US
0.03
3.25%
Healthcare
Biotechnology
30/06/2024
20/03/2026
0.95
0.91
0.96
0.89
AquaBounty Technologies Inc. a biotechnology company focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic genomic and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology. It offers AquAdvantage Salmon a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon salmon eggs fry and byproducts. The company was formerly known as Aqua Bounty Farms Inc. and changed its name to AquaBounty Technologies Inc. in June 2004. AquaBounty Technologies Inc. was incorporated in 1991 and is headquartered in Maynard Massachusetts.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
49.7%1 month
73.9%3 months
89.5%6 months
98.6%-
-
0.04
0.10
0.08
0.02
7.45
-
-24.31M
3.67M
3.67M
-
-2.80K
-
-77.10
-53.94
2.41
2.37
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.15
Range1M
0.20
Range3M
0.44
Rel. volume
1.14
Price X volume
36.03K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Neurotrope Inc | NTRP | Biotechnology | 2.54 | 4.03M | 5.83% | n/a | 0.00% |
| Cyclerion Therapeutics Inc | CYCN | Biotechnology | 1.59 | 4.00M | 5.30% | n/a | 0.00% |
| Jaguar Health Inc | JAGX | Biotechnology | 0.4194 | 3.88M | 0.33% | 0.25 | 176.14% |
| NuCana plc | NCNA | Biotechnology | 1.65 | 3.71M | -3.51% | n/a | 0.00% |
| Iterum Therapeutics plc | ITRM | Biotechnology | 0.1613 | 3.66M | -5.45% | n/a | -198.11% |
| 60 Degrees Pharmaceuticals Inc. Common Stock | SXTP | Biotechnology | 1.95 | 3.63M | 1.04% | n/a | 5.19% |
| QNCX | QNCX | Biotechnology | 0.08 | 3.46M | -8.78% | n/a | 30.62% |
| XTL Biopharmaceuticals Ltd | XTLB | Biotechnology | 0.59 | 3.21M | -0.17% | n/a | 0.00% |
| Matinas BioPharma Holdings Inc | MTNB | Biotechnology | 0.64 | 3.21M | 8.47% | n/a | 16.97% |
| Soligenix Inc | SNGX | Biotechnology | 1.2 | 2.74M | -1.64% | n/a | 84.28% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.3938 | 3.75M | 0.31% | n/a | 19.98% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.23 | 3.14M | n/a | 17.32% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.09 | 1.15M | -2.34% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.02 | - | Cheaper |
| Ent. to Revenue | 7.45 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.04 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 89.52 | - | Riskier |
| Debt to Equity | 0.10 | -1.23 | Expensive |
| Debt to Assets | 0.08 | 0.25 | Cheaper |
| Market Cap | 3.67M | - | Emerging |